Kim P.  Kamdar net worth and biography

Kim Kamdar Biography and Net Worth

Director of Evofem Biosciences
Dr. Kamdar has served as a member of the Evofem Biosciences board of directors since January 2018 and is currently the Chair of the Nominating Committee. Dr. Kamdar is a Managing Partner of Domain Associates, LLC, a life sciences venture capital firm, which she joined in 2005. Dr. Kamdar is current Chair of the board of directors and CEO of Aspen Neuroscience and chair of the board of directors of Truvian Sciences. She also serves on the board of directors of Epic Sciences, Obalon Therapeutics, Omniome, ROX Medical, Sera Prognostics and Singular Genomics. Past investments include Ariosa (acquired by Roche), Corthera (acquired by Novartis), BiPar Sciences (acquire by Sanofi-Aventis) and Achaogen.

Formerly, Dr. Kamdar was a Kauffman Fellow with MPM Capital. Prior to joining MPM, Dr. Kamdar was a research director at Novartis, where she built and led a research team that focused on the biology, genetics and genomics of model organisms. Dr. Kamdar is the author of ten papers as well as the inventor on seven patents. Dr. Kamdar received her B.A. from Northwestern University and Ph.D. in biochemistry and genetics from Emory University.

Dr. Kamdar serves as an advisory board member of Dr. Eric Topol's NIH supported Clinical and Translational Science Award for Scripps Medicine and is also on the non-profit board for Access Youth Academy, an organization that is transforming the lives of underserved youth through academic enrichment, health and wellness, social responsibility and leadership through squash.

What is Kim P. Kamdar's net worth?

The estimated net worth of Kim P. Kamdar is at least $1,294.89 as of August 14th, 2023. Ms. Kamdar owns 132,132 shares of Evofem Biosciences stock worth more than $1,295 as of November 22nd. This net worth evaluation does not reflect any other assets that Ms. Kamdar may own. Learn More about Kim P. Kamdar's net worth.

How do I contact Kim P. Kamdar?

The corporate mailing address for Ms. Kamdar and other Evofem Biosciences executives is 12400 HIGH BLUFF DRIVE SUITE 600, SAN DIEGO CA, 92130. Evofem Biosciences can also be reached via phone at (858) 550-1900 and via email at [email protected]. Learn More on Kim P. Kamdar's contact information.

Has Kim P. Kamdar been buying or selling shares of Evofem Biosciences?

Kim P. Kamdar has not been actively trading shares of Evofem Biosciences within the last three months. Most recently, on Friday, June 18th, Kim P. Kamdar bought 80 shares of Evofem Biosciences stock. The stock was acquired at an average cost of $146.25 per share, with a total value of $11,700.00. Following the completion of the transaction, the director now directly owns 154 shares of the company's stock, valued at $22,522.50. Learn More on Kim P. Kamdar's trading history.

Who are Evofem Biosciences' active insiders?

Evofem Biosciences' insider roster includes Russell Barrans (Insider), Justin File (CFO), Alexander Fitzpatrick (General Counsel), Kim Kamdar (Director), Anthony O'Brien (Director), Saundra Pelletier (CEO), and Lisa Rarick (Director). Learn More on Evofem Biosciences' active insiders.

Kim P. Kamdar Insider Trading History at Evofem Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/18/2021Buy80$146.25$11,700.00154View SEC Filing Icon  
6/12/2020Buy40$367.50$14,700.0074View SEC Filing Icon  
5/21/2019Sell5$633.75$3,168.75View SEC Filing Icon  
See Full Table

Kim P. Kamdar Buying and Selling Activity at Evofem Biosciences

This chart shows Kim P Kamdar's buying and selling at Evofem Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Evofem Biosciences Company Overview

Evofem Biosciences logo
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.01
Low: $0.01
High: $0.01

50 Day Range

MA: $0.01
Low: $0.01
High: $0.01

2 Week Range

Now: $0.01
Low: $0.01
High: $0.23

Volume

308,508 shs

Average Volume

953,531 shs

Market Capitalization

$1.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A